Sökning: "pharmaceutical firm"
Visar resultat 16 - 20 av 27 uppsatser innehållade orden pharmaceutical firm.
16. Key Factors for Successful Development and Implementation of Electronic Data Capture in Clinical Trials
Master-uppsats, Uppsala universitet/Industriell teknikSammanfattning : Drug development in general and clinical trials in particular is expensive and time consuming processes. One mandatory procedure in clinical trials are data collection, about 15 years ago almost all data were collected with a paper based approach but with new digitalised technology for data collection the process were about to become more efficient in regard to time, cost and quality of data. LÄS MER
17. Adapted Value Chain Analysis for Market Assessment of Emerging Life Science Markets. : A CASE STUDY OF A SWEDISH BIOTECH FIRM’S PROSCPECTS ON THE RUSSIAN MARKET
Kandidat-uppsats, Uppsala universitet/Företagsekonomiska institutionenSammanfattning : Over the last decade, the life science industry has been facing shrinking revenues accompanied by increasing R&D costs, which resulted in an industry wide crisis acting as a catalyst for a change of the business model in the entire field of life science business. Emerging life science markets of the developing countries are growing rapidly and Western companies in this knowledge intensive industry have to expand in order to capture the scarce revenues. LÄS MER
18. Exploring Trust and Commitment in Inter-firm Relationships when Outsourcing R&D : A Qualitative Study of Pharmaceutical Firms and Clinical Research Organizations
Master-uppsats, Företagsekonomiska institutionenSammanfattning : The Swedish pharmaceutical industry is going through structural changes due to the increased cost of drug development. This has led pharmaceutical firms to outsource clinical trials to Clinical Research Organisations (CRO). LÄS MER
19. Uppgiftsskydd och marknadsexklusivitet: Två nya immaterialrättigheter i EU:s läkemedelslagstiftning
Kandidat-uppsats, Lunds universitet/Institutionen för handelsrättSammanfattning : Data exclusivity and marketing exclusivity are two new forms intellectual property rights, for the benefit of pharmaceutical companies. They constitute a complement to other IPRs, including patent and copyright, and are intended to provide new pharmaceutical products with a limited time of protection against competition. LÄS MER
20. Mega Acquisition in the Pharmaceutical Industry: Analysis of the Industry Rivals’ Wealth Effects in the Pfizer – Wyeth Case
Magister-uppsats, Lunds universitet/Företagsekonomiska institutionenSammanfattning : Examination of the post-announcement abnormal returns of the industry rivals and the firm specific characteristics in order to identify which of them determine the post-announcement wealth effects and in which way.... LÄS MER